Viewing Study NCT05599334

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 2:21 AM

Ignite Modification Date: 2026-01-22 @ 12:07 AM

Study NCT ID: NCT05599334

Status: COMPLETED

Last Update Posted: 2025-10-06

First Post: 2022-02-10

Is Gene Therapy: True

Has Adverse Events: True

Brief Title: A Retrospective Observational Study of Patients With Early-stage HER2-positive Breast Cancer, Treated With Neratinib

Sponsor: Pierre Fabre Medicament

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module References Module Adverse Events Module Baseline Characteristics Module Participant Flow Module